etoposide has been researched along with deferoxamine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Basha, MT; Bernhardt, PV; Jansson, PJ; Kalinowski, DS; Lovejoy, DB; Obeidy, P; Prichard, T; Richardson, DR; Seebacher, N; Sharp, DM; Sharpe, PC; Stefani, C | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Amici, A; Angioni, A; Caniglia, M; De Sio, L; Deb, G; Dominici, C; Donfrancesco, A; Fidani, P; Helson, L | 1 |
| Bagnulo, S; Carli, M; Casale, F; De Bernardi, B; De Sio, L; Deb, G; Donfrancesco, A; Helson, L; Mancini, A; Nigro, M | 1 |
| Gantchev, T; Kagan, V; Stoyanovsky, D; Yalowich, J | 1 |
| Angioni, A; Boglino, C; Cozza, R; Deb, G; Donfrancesco, A; Helson, L; Jenkner, A; Landolfo, A; Maurizio, C | 1 |
| Czene, S; Harms-Ringdahl, M; Tibäck, M | 1 |
| Fales, I; Hrubá, A; Kavan, P; Kobylka, P; Matĕjcková, S; Skala, JP; Starý, J; Vodvárková, S | 1 |
| Fukuchi, K; Gomi, K; Tomoyasu, S; Tsuruoka, N; Watanabe, H | 1 |
| Fukuchi, K; Gomi, K; Nakamaki, T; Tomoyasu, S; Tsuruoka, N | 1 |
1 review(s) available for etoposide and deferoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for etoposide and deferoxamine
| Article | Year |
|---|---|
Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Deferoxamine; Etoposide; Humans; Infant; Neoplasm Staging; Neuroblastoma; Risk Factors; Thiotepa | 1995 |
D-CECaT: a breakthrough for patients with neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Deferoxamine; Etoposide; Humans; Infant; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Thiotepa | 1993 |
9 other study(ies) available for etoposide and deferoxamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Copper; Crystallography, X-Ray; Dimerization; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Injections, Intravenous; Ketones; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Oxidation-Reduction; Pyridines; Structure-Activity Relationship; Thiosemicarbazones; Transferrin; Transplantation, Heterologous | 2012 |
Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Chelation Therapy; Child; Child, Preschool; Cyclophosphamide; Deferoxamine; Etoposide; Humans; Infant; Neuroblastoma; Pilot Projects; Remission Induction; Thiotepa | 1992 |
Tyrosinase-induced phenoxyl radicals of etoposide (VP-16): interaction with reductants in model systems, K562 leukemic cell and nuclear homogenates.
Topics: Ascorbic Acid; Cell Nucleus; Chromatography, High Pressure Liquid; Deferoxamine; Electron Spin Resonance Spectroscopy; Etoposide; Free Radicals; Glutathione; Humans; Leukemia; Monophenol Monooxygenase; Oxidation-Reduction; Phenols; Thioctic Acid; Tumor Cells, Cultured | 1993 |
pH-dependent DNA cleavage in permeabilized human fibroblasts.
Topics: Apoptosis; Catalase; Cell Line; Cell Membrane Permeability; Deferoxamine; Dimethyl Sulfoxide; DNA; Electrophoresis, Agar Gel; Endonucleases; Etoposide; Fibroblasts; Humans; Hydrogen-Ion Concentration; Reactive Oxygen Species; Superoxide Dismutase | 1997 |
[Purging of hemopoietic progenitor cells in autologous transplantation].
Topics: Adult; Bone Marrow Purging; Child; Cyclophosphamide; Deferoxamine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Methylprednisolone; Neuroblastoma; Transplantation, Autologous | 1997 |
G1 accumulation caused by iron deprivation with deferoxamine does not accompany change of pRB status in ML-1 cells.
Topics: Cell Division; Cell Line; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Cytarabine; Deferoxamine; Etoposide; Gene Expression; Humans; Phosphorylation; Proto-Oncogene Proteins; Retinoblastoma Protein; RNA, Messenger; Tumor Suppressor Protein p53 | 1997 |
DNA damage induces p21 protein expression by inhibiting ubiquitination in ML-1 cells.
Topics: Acetylcysteine; Cell Nucleus; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Proteinase Inhibitors; Cytarabine; Deferoxamine; DNA Damage; Etoposide; Gene Expression Regulation; Hydroxyurea; Polyribosomes; RNA, Messenger; Tumor Cells, Cultured; Ubiquitins | 1998 |